Join to view full profile
Cedars Sinai127 S San Vicente BlvdLos Angeles, CA 90048
Dr. Malatt is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2017 - 2020
University of California (San Diego) Medical CenterInternship, Preliminary Year, 2016 - 2017
University of California San Diego School of MedicineClass of 2016
Certifications & Licensure
CA State Medical License 2017 - 2027
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 3 citationsAdrenergic blockers, statins, and non-steroidal anti-inflammatory drugs are associated with later age at onset in Parkinson's disease.Camille Malatt, Helia Maghzi, Elliot Hogg, Echo Tan, Ishani Khatiwala
Journal of Neurology. 2025-03-06 - 10 citationsThe role of the locus coeruleus/norepinephrine system in the pathogenesis of neurodegenerative disorders: An update.Camille Malatt, Michele Tagliati
Current Opinion in Neurology. 2022-04-01 - 29 citationsLong-Term Outcomes of Deep Brain Stimulation for Pediatric Dystonia.Camille Malatt, Michele Tagliati
Pediatric Neurosurgery. 2022-01-01
Authored Content
- NSAIDs, Statins, & ABs Linked to Delayed Onset of Parkinson’s DiseaseApril 2025
Press Mentions
Common Medications Tied to Older Age at Onset of Parkinson’s DiseaseApril 25th, 2025- NSAIDs, Statins, & ABs Linked to Delayed Onset of Parkinson’s DiseaseApril 24th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
